WHO & MPP Foster Tech Transfer License for Diagnostics

WHO and Medicines Patent Pool Announce License Agreement to Manufacture Rapid Diagnostic Tests

The World Health Organization (WHO) and the Medicines Patent Pool (MPP) have announced a license agreement with SD Biosensor Inc., a global in-vitro diagnostic company, to provide sublicensees with the right, know-how, and material to manufacture SD Biosensor’s rapid diagnostic testing (RDT) technology. This license agreement, negotiated under the COVID-19 Technology Access Pool (C-TAP), represents a significant milestone in the initiative’s evolution as it enables the manufacture of diagnostics for COVID-19, as well as other diseases such as HIV, malaria, and syphilis.